Rationale The reinforcing effects of cocaine are mediated by the mesolimbic dopamine system. Behavioral and neurochemical studies have shown that the cholinergic muscarinic M 4 receptor subtype plays an important role in regulation of dopaminergic neurotransmission. Objectives Here we investigated for the first time the involvement of M 4 receptors in the reinforcing effects of cocaine using chronic intravenous cocaine self-administration in extensively backcrossed M 4 receptor knockout (M 4
Introduction
The activity of midbrain dopaminergic neurons projecting to the nucleus accumbens (NAc) is believed to mediate the reinforcing effects of drugs of abuse (Koob 1992; Koob et al. 1998; Wise 1996) . The M 4 muscarinic receptor, one of the five muscarinic acetylcholine receptor subtypes (M 1 -M 5 ), is highly expressed in the central nervous system, Electronic supplementary material The online version of this article (doi:10.1007/s00213-011-2225-4) contains supplementary material, which is available to authorized users.
particularly in the striatum and also, at lower levels, in the cerebral cortex, hippocampus, and midbrain (Levey 1993; Sugaya et al. 1997; Vilaro et al. 1993; Yasuda et al. 1993 ). In the striatum, M 4 receptors are co-expressed with D1 dopamine receptors on striatal projection neurons (Weiner et al. 1990 ). M 4 receptors are structurally closely related to M 2 receptors, both couple to G proteins of the G i /G o family and inhibit adenylyl cyclase, thereby reducing cAMP formation (Olianas et al. 1996) . The precise functional roles of the individual muscarinic acetylcholine receptor subtypes have remained elusive due to their overlapping expression pattern and the lack of subtype specific ligands. To overcome these obstacles, muscarinic receptor knockout mice have been developed (Wess et al. 2007 ). Gomeza et al. (1999) showed that M 4 receptor knockout (M 4 −/− ) mice display increased basal locomotor activity and increased hyperlocomotion induced by the nonselective dopamine agonist apomorphine and by the selective dopamine D 1 receptor agonist SKF 38393. Furthermore, M 4 −/− mice displayed enhanced striatal dopamine efflux in response to amphetamine and phencyclidine (Tzavara et al. 2004 ). However, it has not been investigated whether the M 4 receptor plays a role in the reinforcing effects of drugs of abuse.
In the present study, we investigated chronic cocaine self-administration in M 4 −/− and control mice (M 4 +/+ ) under a broad range of conditions in experimentally naïve mice. The effects of cocaine at various doses were determined under a fixed ratio 1 (FR 1) and a progressive ratio (PR) schedule of reinforcement. Food-maintained behavior was also evaluated to assess general operant performance under FR 1 and PR schedules. Furthermore, we tested the effects of cocaine on extracellular levels of dopamine in NAc using in vivo microdialysis as well as on locomotor activity in M 4 −/− and M 4 +/+ mice. To ensure that the obtained results
were not caused by basal behavioral phenotype differences or changes in dopamine D 1 or D 2 receptor expression, we performed the SHIRPA behavioral phenotype assessment as well as dopamine D 1 and D 2 receptor autoradiography.
Materials and methods
Animals M 4 −/− mice were generated as previously described (Gomeza et al. 1999) . Founder mice of mixed genetic background (129SvEv/CF1) were backcrossed to the C57BL/6Ntac strain for 11 generations. ) were bred at the animal facilities at the Panum Institute, University of Copenhagen. Genotyping was performed on mouse-tail DNA using the polymerase chain reaction. Mice were acclimatized to the animal facilities, where experiments were conducted, for at least 1 week prior to experiments. We used group-housed (Macrolon type III cages) male mice (8-14 weeks, 22.0-32.5 g at the start of experiments) kept on a 12-h light/dark cycle in a temperature (22-24°C) and humidity (55%) controlled room. Food and water were available ad libitum, except in cocaine self-administration experiments, where food was available ad libitum until operant training started and was then delivered once daily after self-administration sessions (~3.7 g/day per mouse). Experiments were conducted during the light phase (8:00 a. m.-6:00 p.m.). All procedures were conducted in accordance with guidelines from the Animal Experimentation Inspectorate, Denmark and the European Communities Council Directive of 24 November 1986 (86/609/EEC).
Drugs used for behavioral studies Cocaine hydrochloride was obtained from the Copenhagen University HospitalPharmacy. Cocaine hydrochloride was dissolved or diluted in saline, and solutions were adjusted to a pH range of 4.5-7.0 for subcutaneous or intraveneous injections (10 ml/kg).
Chronic self-administration Equipment, training, and evaluation procedures were previously described (Caine et al. 1999; .
Operant chambers Operant chambers (Med Associates, USA) contained two nose-poke holes 10 mm above the grid floor, both equipped with photocells and a discriminative cue light, positioned on either side of a small dishshaped plate into which liquid food could be delivered. Responding in the right hole resulted in delivery of a reinforcer and illumination of the cue light for 20 s, during which additional responses were counted but had no scheduled consequences (i.e., post-reinforcer timeout). Early unpublished observations in rodents in our laboratory (US location) indicated that the left side (which is furthest from the chamber door) was the preferred side. Consequently, we used the right (expected least preferred) side as the reinforced manipulandum.
Catheter implantation surgery and maintenance Under oxygen/isoflurane vapor anesthesia, a catheter (SILASTIC tubing; 0.18-mm inner diameter, 0.41-mm outer diameter) was inserted 1.2 cm into the right or left jugular vein and anchored to the vein with sutures. The catheter ran subcutaneously to the base located above the midscapular region. During the subsequent 7 days of postsurgical recovery, 0.02 ml of 0.9% saline containing heparin (30 U/ml; SAD, Denmark) and antibiotic (cefazolin, 50 mg/ml; Hexal, Germany) was infused daily through the catheter to prevent clotting and infection. Catheter patency was confirmed 7 days after surgery and after completion of each experimental phase by the loss of muscle tone and clear signs of anesthesia within 3 s after infusion of 0.02-0.03 ml ketamine (15 mg/ml; Pfizer, Denmark) plus midazolam (0.75 mg/ml; Matrix Pharmaceuticals, Denmark) in saline.
If catheters failed during the first 10 acquisition sessions (about 15%), the mice were excluded from further experiments. Under the FR 1 schedule, the catheters of three M 4 −/− mice and two M 4 +/+ mice (total, five) failed. Under the PR schedule, the catheters of four M 4 −/− mice and three M 4 +/+ mice (total, seven) failed.
Acquisition of cocaine self-administration behavior in experimentally naïve mice After catheter implantation and recovery, experimentally naïve mice were introduced to the operant chamber with one active (right) and one inactive (left) nose-poke hole for daily 3-h sessions, 5-6 days/week, and with one of three doses of intravenous cocaine (cocaine HCl in 0.9% saline; Copenhagen University HospitalPharmacy, Denmark) as the reinforcer: 0.03, 0.32, or 1.0 mg/kg/infusion. Activation of the right nose-poke hole led to infusion of the reinforcer under a FR 1 schedule. Sessions started immediately before introducing the mice to the operant chambers and, as an exception to the other experiments, no noncontingent infusion was delivered.
Mice were allowed to self-administer cocaine for 10 sessions or until acquisition criteria were met, whichever occurred first. These mice were never food deprived. Criteria for acquisition of self-administration were: (1) ≥15 reinforcers earned per session for two of three consecutive sessions ("acquisition level"), (2) ≥70% responses in the active hole on the second day, (3) extinction of responding when saline was substituted for cocaine (<80% of the acquisition level), and (4) an increase in active responses to or above the acquisition level when cocaine was again made available after extinction. Five M 4 −/− mice and six M 4 +/+ mice did not meet the criteria after 10 sessions at the 0.03 mg/kg/infusion dose; two M 4 −/− mice and three M 4 +/+ mice did not meet criteria after 10 sessions at the 0.32 mg/kg/infusion dose. All mice met criteria at the 1.0 mg/kg/infusion dose. After acquisition, mice were allowed to self-administer 1.0 mg/kg/infusion of cocaine to stable levels before proceeding with the FR 1 or PR schedule. Stable levels are here defined as less than 20% of variation over 3 days. The number of sessions for mice to meet FR 1 criteria with 1.0 mg/kg/infusion of cocaine according to their previous "naive acquisition" dose group were: 0.032 mg/kg/infusion dose group, 2.2 ± 0.26 (n =5); 0.32 mg/kg/infusion dose group, 2.4 ± 0.18 (n = 5); 1.0 mg/kg/infusion dose group, 3.5±0.16 (n=13).
Cocaine self-administration under a FR schedule Cocaine (1.0 mg/kg/infusion) was available in daily 3-h sessions until baseline criteria were met (≥20 reinforcers earned, with ≤20% variation over two consecutive sessions and ≥70% responses in the active hole). In consecutive sessions, saline was substituted for cocaine until extinction criteria were met (<80% of the baseline responding for cocaine self-administration). Subsequently, dose-effect functions (saline, 0.03, 0.1, 0.3, 1.0, 3.2 mg/kg/infusion of cocaine) were determined for each mouse according to a Latin-square design. To prevent overdosing, total drug intake was limited to 30 mg/kg per session.
Liquid food self-administration under a FR schedule Another set of experimentally naïve mice was used for selfadministration of a nondrug reinforcer under FR and PR schedules. The mice were mildly food deprived before the first presentation of liquid food (5 ml of Ensure protein drink, vanilla flavor; Abbott Laboratories, USA) in the operant chamber (i.e., ad libitum dry food in the home cage was removed 18-20 h before the session, water remained available). When ≥1.5 ml of the 5 ml available was consumed per 2-h session, mice were placed in the operant chamber with one active and one inactive nose-poke hole for daily 2-h sessions similar to cocaine FR 1 self-administration. Acquisition lasted for at least five consecutive sessions and until criteria were met (≥20 reinforcers earned, with ≤20% variation over two consecutive sessions and ≥70% responses in the active hole). Subsequently, water was substituted for at least three sessions and until responding was extinguished to <80% of food-maintained responding. Then, a range of liquid food dilutions (water; 3%, 10%, 32%, and 100%) was presented according to a Latin-square design, determined twice in each mouse.
Cocaine self-administration and liquid food maintained behavior under a PR schedule After the FR 1 schedule, mice proceeded with cocaine self-administration under a PR schedule of reinforcement. Mice that had selfadministered liquid food under a FR 1 schedule proceeded in a similar PR schedule with liquid food as the reinforcer. After stable responding under the FR 1 schedule maintained by cocaine (1.0 mg/kg/infusion) or undiluted food, an FR 3 schedule was used as a transition from the FR 1 schedule before introducing the PR schedule. For the PR schedule, the starting ratio was 3, and then increased by 0.115 log units after each reinforcer delivery (i.e., 3, 4, 6, 7, 10, 13, 16, 21, 28, 36…) . The breaking point was defined as the step value associated with the last completed ratio (i.e., number of reinforcers earned) after a 60-min limited hold (i.e., period with no reinforcer earned). If a breaking point was not reached within 6 h, the session was terminated to prevent health hazard, and the last reached ratio was used. After stable baseline was achieved (two consecutive sessions with breaking points >5 and with <20% variation), saline or water was substituted until responding extin-guished to ≤50% of the baseline breaking point. Cocaine dose-effect curves (0.03, 0.3, 1.0, 3.2 mg/kg/infusion cocaine) and liquid food concentration-effect curves (0%, 3%, 10%, 32%, and 100% food in water) were determined according to a Latin-square design, with each dose tested for two or three consecutive sessions (i.e., if the breaking points reached in the two first determinations varied by >20%, a third determination was made).
In vivo microdialysis studies Before surgery the mice received an analgesic (Metacam, Boehringer Ingelheim; 5 mg/kg s.c.). Mice were then anesthetized using sevoflurane (Baxter) and placed in a stereotaxic frame equipped with a mouse adapter (Kopf). Intracerebral guide cannulae (CMA/7, CMA) were stereotaxically implanted into the brain to allow the positioning of the dialysis probe tip in the NAc (AP: +1.0 mm, ML: +0.8 mm, DV: −3.0 mm; Franklin and Paxinos 1997) and fixed in place with two anchor screws and dental cement. Animals were left to recover for at least 2 days. The correct placement of the probe was verified histologically at the end of the experiment. For in vivo microdialysis studies, a Ringer's solution (147 mM NaCl, 4 mM KCl, and 2.3 mM CaCl 2 ) was perfused at a rate of 1.2 μl/min through the probe (CMA 7, 1 mm, cutoff 6,000 Da, CMA) and the microdialysis probe was slowly inserted into the brain through the guide cannulae. Following a 1-h acclimatization period, 20-min samples were collected into a fraction collector. Time points were corrected for lag time of the perfusate from the microdialysis site to the probe outlet. Three samples were collected to establish dopamine baseline levels. Subsequently, mice were injected with physiological saline or cocaine (10 or 30 mg/kg, s.c.) in a between-subjects design, and nine additional samples were collected. Using swivel and bowl, the animals were able to move freely during the dialysis. The samples were stored at −80°C until analysis with high-performance liquid chromatography (HPLC) coupled to electrochemical detection. For measurement of dopamine levels, the collected dialysates (20 μl) were injected onto a Prodigy C18 HPLC column (YMC Europe) by a refrigerated microsampler system (717plus, Waters). Dopamine was separated by reverse phase liquid chromatography using a mobile phase consisting of 97% of 94.2 mM NaH 2 PO 4 , 0.98 mM octanesulfonic acid, 0.06 mM Na 2 EDTA, adjusted to pH 3.7 with 1 M phosphoric acid, and 7% acetonitrile (v/v) at a flow rate of 0.25 ml/min. Electrochemical detection of dopamine was accomplished using a amperimetic detector with a glassy carbon electrode operating at +0.7 V vs. Ag/AgCl reference electrode. Data were collected and analyzed using Empower software (Waters). The limit of detection (at a signal to noise ratio of 1:2) was 3±0.2 fmol/15 μl.
Locomotor activity measurements Mice were injected subcutaneously with saline or cocaine (5, 10, and 30 mg/kg) and immediately transferred to activity test cages with a scant lining of fresh bedding. The test cages were situated in frames emitting eight infrared lines 1.5 cm above the floor. The total number of beam breaks during a 1-h observation period was measured with Photobeam Activity System-Home Cage (Ellegaard Systems) in a between-subjects design.
Behavioral phenotype assessment, primary screen (SHIRPA) Behavioral and physical characteristics of experimentally naïve mice were assessed using the SHIRPA primary screen procedure derived from Irwin (1968) , which comprises several measures covering various reflexes and basic sensorimotor functions (Lalonde et al. 2005; Rogers et al. 1997 Rogers et al. , 1999 . In brief, body weight and body length were measured and assessment of the mice began with observation of undisturbed behavior in a cylindrical clear Perspex viewing jar (14×10 cm in diameter) for 5 min. Here the following was evaluated: body position, spontaneous activity, respiration, and tremor. The mice were then transferred to an arena (55×35×18 cm) for observation of transfer arousal, palpebral closure, piloerection, startle response, gait, pelvic elevation, tail elevation, touch escape, and positional passivity. The mice were then grabbed by the tail and removed from the arena, the absence or presence of trunk curl and limb grasping was recorded. The animal was then lowered towards a grid (20×36 cm, 9 mm in diameter) where visual acuity was evaluated. The mouse was allowed to grip the grid; a gentle backwards pull was applied; and grip strength, body tone, and reflexes of the ears, eyes, and limbs were scored. Subsequently, the mice were hung by their forelegs on a wire (15 cm long, 1 mm in diameter) and behavior was scored. The mice were then restrained in a supine position to record skin color, heart rate, limb tone, abdominal tone, lacrimation, salivation, and provoked biting. The screen was completed with the measurement of the righting reflex, contact righting reflex, and negative geotaxis. Throughout the procedure, incidences of abnormal behavior, fear, irritability, aggression, or vocalization were recorded. Viewing jar and arena were thoroughly cleaned between each mouse.
Basal locomotor activity was measured in monitoring frames equipped with seven horizontal infrared light beams along the long axis of the frame placed 4.3 cm apart and 3.3 cm above the surface. Standard cages (Macrolon type III) with a scant lining of fresh wood-chip bedding were placed in the monitoring frames and covered with Perspex tops with ventilation holes. The setup was situated in a ventilated soundproof room with dimmed light settings. A computer program (YMOT16) recorded interruptions of the light beams as counts of photo beam breaks in minimum intervals of 1 min. Basal locomotor activity was measured for 150 min. Autoradiographic detection of D2-family receptors The brain sections were preincubated in a buffer containing 50 mM TRIS base, 120 mM NaCl, 5 mM KCl, 2 mM CaCl2, and 1 mM MgCl2 at 0°C for 15 min before being incubated with 3[H]raclopride (4 nM, PerkinElmer Danmark A/S, Hvidovre, Denmark, 60.1 Ci/mmol) for 1 h at 4°C in the same buffer, followed by two 30-min washes at 0°C in buffer. Nonspecific binding was determined in the presence of 10 μM sertindole (H. Lundbeck, Valby, Denmark), a D2-, 5-HT2-, and alpha1 receptor antagonist. Slides were further processed as described above. Exposure time was 40 days for both CPu/NAc and VTA/SN. Developed films were analyzed with a computer-assisted video densitometer (Scion-Image; Scion Corporation, Frederick, MD) using the standard curve generated from 3H standards (Amersham Biosciences, Hillerød, Denmark).
Data analysis Cocaine-induced locomotor activity results were analyzed by two-way ANOVA followed by Bonferroni-corrected pair wise comparisons. Extracellular dopamine levels measured by microdialysis are represented as percentage increase relative to baseline levels (−40-0 min). These data were analyzed using a mixed-model ANOVA followed by a Bonferroni post-hoc test. The 20-80-min microdialysis intervals were analyzed by two-way ANOVA followed by Student's t test. For cocaine selfadministration, latencies to acquisition of selfadministration were compared between genotypes using log-rank test. The number of sessions before criteria for different experimental phases were compared between genotypes using Student's t test. Cocaine dose-effect and food concentration-effect functions determined under the FR schedule were analyzed using mixed-model ANOVA with genotype as between-subjects variable and cocaine dose or food concentration as within-subjects variables. PR schedule data were analyzed using two-way ANOVA with genotype and cocaine dose or food concentration as between-subjects variables. Significant effects were followed with post-hoc Student's t test. Animals with extreme values, defined as more than three interquartile ranges below or above the 25th and 75th percentile, respectively, were excluded from statistical analysis (SPSS Inc. 2004 ). This resulted in exclusion of one M 4 +/+ mouse from the FR 1 cocaine study. D1 and D2 receptor density was determined for each animal with a total of six measurements for each brain area (each cerebral hemisphere in three sections). The mean of these six measurements was used for further statistical analysis for each animal and brain area. Two-tailed independent samples Student's t test was used to compare the M 4 −/− and M 4 +/+ mice. For the SHIRPA procedure, body weight, body length, and spontaneous locomotor activity were analyzed using Student's t test. Scores of remaining parameters of the SHIRPA procedure were compared using Mann-Whitney U test. Data are presented as mean±SEM if not otherwise stated. A p value of <0.05 was considered significant.
Results
Acquisition of cocaine self-administration behavior in experimentally naïve mice Acquisition of cocaine selfadministration behavior was examined in experimentally naïve mice that were introduced to the operant chamber with a dose of 0.03, 0.3, or 1.0 mg/kg/infusion of cocaine.
No noncontingent infusion was delivered to these mice and they were tested until acquisition criteria were met or for 10 sessions, whichever occurred first. The mean number of sessions before criteria were met and the percentage of mice that met criteria within the 10 sessions are shown in Fig. 1a and b. M 4 −/− and M 4 +/+ mice required similar number of sessions to meet acquisition criteria at all doses. Furthermore, comparison of acquisition with the log-rank test revealed no differences between the genotypes at any of the doses.
Cocaine self-administration under FR 1 and PR schedules of reinforcement Table 1 Fig. 1 Acquisition of cocaine self-administration behavior in experimentally naïve M 4 −/− mice (white) and M 4 +/+ mice (black). a Number of sessions before acquisition criteria were met. b Percentage of mice that met criteria for cocaine self-administration. Abscissas, unit dose of cocaine (mg/kg/infusion). Ordinates, sessions before criteria were met (a) and percentage of mice that acquired self-administration behavior (b). Group sizes, n=8-9. The M 4 −/− mice did not differ from their wild-type littermates in acquisition of cocaine self-administration behavior −/− mice (white) and wildtype littermates (black). Abscissas, unit dose of cocaine in saline (mg/ kg/infusion). Ordinates, reinforcers earned under the FR 1 (reinforcers per hour, a) and under the PR (breaking point, b) schedule of reinforcement. The final ratio corresponding to each breaking point is indicated in parentheses for the PR schedule. Group means were calculated from the average for each mouse of two determinations per dose evaluated according to a Latin-square design. Group sizes: FR 1 schedule, n=10-13; PR schedule, n=8. A significant main effect of genotype was found under both FR 1 and PR schedules of reinforcement. M 4 −/− mice exhibited higher response rates than wildtype mice at doses of 0.3 and 1.0 mg/kg/infusion under the FR 1 schedule. Under the PR schedule of reinforcement, M 4 −/− mice reached higher breaking points than wild-type mice at the 1.0 mg/kg per infusion dose. *p<0.05, **p<0.01, ***p<0.001 vs. wild type; post-hoc t test following overall significant genotype effect in twoway ANOVA Under the PR schedule of reinforcement, two-way ANOVA similarly showed significant effects of cocaine dose (F 67,4 , 92.8%) and log-rank test revealed no effect of genotype. Furthermore, the number of sessions necessary to meet criteria for the different experimental phases (Table 1) Cocaine-induced dopamine release in NAc is enhanced in M 4 −/− mice We used in vivo microdialysis to investigate whether extracellular dopamine levels were altered in the NAc of M 4 −/− mice, as compared to control littermates.
Two-way mixed-model ANOVA showed a significant effect of treatment (F 5,290 =29.6, p<0.001), time (F 10,290 =46.4, p<0.001) as well as interaction (F 50,290 =12.4, p<0.001) on extracellular dopamine level. Post-hoc analysis showed that cocaine, 10 and 30 mg/kg induced a significant increase in extracellular dopamine in both genotypes compared to saline (F 2,9 =12.6; p=0.0047, F 2,9 =2,037; p<0.0001) (Fig. 4 inset) . Cocaine 30 mg/kg resulted in a dramatic increase in extracellular dopamine in M 4 −/− mice as compared to M 4 +/+ mice (20-120 min, p<0.001-0.05) (Fig. 4) . Following saline injections, no differences in extracellular dopamine levels were observed between the two genotypes. Microdialysate concentrations in saline treated M 4 −/− and M 4 +/+ mice were not significantly different (9.2±0.8 and 8.9±1.4 fmol/15 μL, respectively).
Cocaine-induced hyperlocomotor responses are increased in M 4 −/− mice We performed locomotor activity measurements following administration of cocaine (5-30 mg/kg, s.c.), a psychostimulant that increases synaptic dopamine levels by blocking the dopamine transporter. In both M 4 −/− mice and their wild-type littermates (M 4 +/+ mice), cocaine caused dose-dependent increases in locomotor activity (Fig. 5) . Cocaine, 30 mg/kg, induced a significantly greater locomotor response in M 4 −/− than in M 4 +/+ mice (p<0.05).
Basal behavioral testing (primary screen) We subjected naïve M 4 −/− mice and control littermates to a series of basic tests examining reflexes and sensorimotor functions, using −/− mice reached higher breaking points at a concentration of 3% liquid food. **p<0.01 vs. wild type; post-hoc t test following overall significant genotype effect in two-way ANOVA the SHIRPA primary screen procedure (Rogers et al. 1997 (Rogers et al. , 1999 . We found no significant differences between the two genotypes in any of the measures investigated (Supplemental Table 1 ). D 1 and D 2 receptor autoradiography Receptor autoradiography on D 1 and D 2 receptors was performed to investigate potential compensatory changes in the density of dopamine receptors induced by the knockout of the M 4 receptor gene. The investigated brain areas were selected because of their involvement in dopaminergic projections of importance for locomotion and reward. These included the PFC, CPu, NAc, and VTA/SN. In addition, the olfactory tubercle was studied because of the high density of dopamine receptors in this area. However, D 2 receptor binding was not measured in the PFC because this receptor is not detectable in this structure of the mouse brain (Camps et al. 1990 ). D 2 receptor binding was also below detection limit in the VTA/ SN region in the present study. No differences in D 1 or D 2 receptor binding were found in any of the analyzed brain regions between M 4 −/− and M 4 +/+ mice (Table 2 and Fig. 6 ).
Discussion
In the present study, we show for the first time that cocaine selfadministration is increased in M 4 −/− mice compared to M 4 +/+ mice. This effect was observed at intermediate doses of cocaine under both a FR and a PR schedule of reinforcement.
To support these findings, we measured extracellular concentrations of dopamine in the NAc of M 4 −/− and M 4 +/+ mice using in vivo microdialysis. We found that the cocaineinduced increase in NAc dopamine levels was strongly augmented in M 4 −/− mice compared to M 4 +/+ mice. In agreement with these results, we found that cocaine-induced hyperactivity was increased in M 4 −/− mice compared to M 4 +/+ mice. These differences could not be explained by changes in sensorimotor or behavioral phenotype or differences in D 1 or D 2 receptor density between the genotypes. Cocaine self-administration dose-effect functions were investigated under a FR 1 schedule of reinforcement, and M 4 −/− mice showed increased response rates No differences in the ability to acquire selfadministration were observed, as similar percentages of experimentally naïve M 4 −/− and M 4 +/+ mice met acquisition criteria and similar numbers of sessions were required for both genotypes to meet criteria at three doses of cocaine. Upward shifts of the dose-effect function have been related to a phenotype with increased propensity to develop Table 2 for quantitative data). Scale bar=1 mm ND not determined drug addiction (Piaza et al. 2000) and taken together with the microdialysis data presented here, we propose increased reinforcing efficacy of cocaine in M 4 −/− mice. differences in acquisition and extinction of food-maintained behavior under either FR 1 or PR schedules were observed, and consequently, M 4 receptor deletion may also change operant responding for food. These effects did not appear to affect body weight that was similar in the two genotypes. However, the observed effects of M 4 receptor knockout on food-maintained operant behavior open up the possibility for a more general role of the muscarinic M 4 receptor in motivated behavior. We observed no differences in sensorimotor and behavioral parameters between M 4 +/+ and M 4 −/− mice and we also found no significant differences between basal dopamine effluxes in NAc in the two groups of mice. Several lines of transgenic knockout mice have been studied in cocaine self-administration paradigms. Such studies have revealed that engineering of only three gene products for which knockout decreased or abolished cocaine self-administration in mice: knock-in of the dopamine transporter, knockout of the dopamine D1 receptor, and knockout of the metabotropic glutamate mGluR5 receptor (Chiamulera et al. 2001; Caine et al. 2007; Thomsen et al. 2009a) . Although early studies in food-trained mice suggested that DAT −/− mice did selfadminister cocaine (Rocha et al. 1998a ), more recent investigations using a wider range of conditions indicated that cocaine self-administration was decreased in both DAT −/− mice and lacking in mice carrying a cocaineinsensitive DAT (Rocha et al. 1998a; Thomsen et al. 2009a, b) . It is noteworthy that this opposite effect on cocaine selfadministration of the D 1 and M 4 null mutation is in agreement with the opposing effects of these receptors at the cellular level (Hulme et al. 1990; Ince et al. 1997 ).
Conversely, a few strains have also shown increased cocaine self-administration under some conditions, such as mice lacking the dopamine D 2 or the 5HT1B receptor (Rocha et al. 1998b; Caine et al. 2002) . The present results with M 4 −/− mice likely represent a different mechanism of increased reinforcement than those two previous studies. Indeed in D2 −/− mice, cocaine self-administration was increased at high doses only (i.e., rightward shift relative to the presently observed upward shift), whereas in 5HT-1B −/− mice increase self-administration was seen only under a PR schedule of reinforcement, not under the FR 1 schedule (Rocha et al. 1997 (Rocha et al. , 1998b Caine et al. 2002) .
Regarding the cholinergic system, we have earlier shown that cocaine self-administration was moderately decreased in M 5 −/− mice (Fink-Jensen et al. 2003; ). Muscarinic receptors M 1 -M 3 have not been characterized in self-administration models. M 4 receptors are co-localized with D 1 receptors on GABAergic projections to the midbrain of intact mice (Di Chiara et al. 1994) , and the lack of M 4 receptors co-localized with D 1 receptors on GABAergic projections may indirectly activate dopamine firing (Tzavara et al. 2004) . We have recently reported increased behavioral sensitization following treatment with cocaine in mice exclusively lacking M 4 receptors co-localized with D 1 receptors (Jeon et al. 2010) . Taken together, we suggest that the M 4 receptor inhibits the reinforcing properties of cocaine through actions on GABAergic medium spiny projection neurons, decreasing the input to dopaminergic projections to the NAc. Selective M 4 receptor ligands are therefore an interesting target for the treatment of drug abuse. To this end, highly selective positive allosteric modulators of the M 4 receptor have recently been developed Chan et al. 2008; Shirey et al. 2008 ) and these were able to reverse amphetamine-induced hyperlocomotion in rats .
Thus, investigation of the effects these new allosteric modulators on cocaine self-administration are warranted.
Previous studies reported that M 4 −/− mice exhibit increased basal locomotor activity (Gomeza et al. 1999 ) and increased levels of extracellular dopamine in NAc (Tzavara et al. 2004) . In the present study, no significant difference in basal locomotor activity between M 4 −/− and M 4 −/− mice was measured (Fig. 5) . These apparent discrepancies could be due to differences in mouse genetic background. Gomeza et al. (1999) and Tzavara et al. (2004) used mice maintained on a mixed genetic background whereas the mice used in the present study were extensively backcrossed to the C57BL/ 6Tac strain in order to limit the contribution of genetic background (Gerlai 1996) . While it cannot be excluded that some compensatory changes occurred in the constitutive M 4 −/− mice that could have contributed to the observed effects, no such changes have been observed, to the extend that they have been investigated. Generally, knockout mice lacking either one of the five muscarinic receptor subtypes have not displayed measurable changes in the levels of the other subtypes (see Wess 2004 for review). Specifically for M 4 −/− mice, M 2 receptor brain and spinal cord expression levels were evaluated, and found unaltered (Gomeza et al. 1999; Chen et al. 2005) . In addition, M 1 and M 2 receptor levels were normal in mice lacking M 4 receptors in D1-expressing cells, in which total M 4 expression was almost abolished (Jeon et al. 2010 ). The observed difference in cocaine self-administration between M 4 −/− and control mice is most likely not due to changes in dopamine D 1 or D 2 receptor expression, since no significant differences in dopamine D 1 and D 2 receptor densities were observed in PFC, Cpu, NAc or VTA/SN, and Cpu and NAc, respectively (dopamine D 2 receptor levels could not be quantified in PFC and VTA/SN).
In conclusion, M 4 −/− mice exhibited upward shifts in cocaine self-administration dose-effect functions and increased responding for a food reinforcer. Exaggerated increases in extracellular dopamine in response to cocaine as well as increased cocaine-induced locomotor activation were also observed, suggesting increased abuse-related effects of cocaine. Our data suggest that the M 4 receptor among other effects is involved in modulating the reward circuitry and may represent an interesting new target for the pharmacological treatment of cocaine addiction.
